Expertise in
47
conditions

Arsene M. Mekinian

Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
47
conditions
Paris, FR 

Overview

Arsene Mekinian practices practicing medicine in Paris, France.

Mr. Mekinian is highly rated in 47 conditions, according to our data. His clinical expertise encompasses VEXAS Syndrome, Takayasu Arteritis, Vasculitis, Bone Marrow Transplant, and Bone Graft.

He is actively involved in clinical research, co-authoring 389 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
Saint Antoine, France
Paris Est Créteil University, Creteil, France
Bobigny, France
Pierre-la-treiche, France
Bondy, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis: a Phase II, Randomized, Controlled Trial
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis: a Phase II, Randomized, Controlled Trial
Enrollment Status: Recruiting
Publish Date: November 20, 2025
Intervention Type: Drug
Study Drug: Itacitinib
Study Phase: Phase 2
Regulatory T-cell Induction by Low-dose Interleukin-2 in Women With Unexplained Repeated Spontaneous Early Miscarriages
Regulatory T-cell Induction by Low-dose Interleukin-2 in Women With Unexplained Repeated Spontaneous Early Miscarriages
Enrollment Status: Completed
Publish Date: September 12, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase II Study of Efficacy and Tolerance of Azacitidine (AZA) In MDS-associated Steroid Dependent/Refractory Systemic Auto-immune and Inflammatory Disorders (SAID)
A Phase II Study of Efficacy and Tolerance of Azacitidine (AZA) In MDS-associated Steroid Dependent/Refractory Systemic Auto-immune and Inflammatory Disorders (SAID)
Enrollment Status: Completed
Publish Date: October 04, 2022
Intervention Type: Drug
Study Phase: Phase 2
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
Efficacy and Tolerance of First-line Treatment With Tocilizumab in Active Takayasu Arteritis French Prospective Multicenter Study
Efficacy and Tolerance of First-line Treatment With Tocilizumab in Active Takayasu Arteritis French Prospective Multicenter Study
Enrollment Status: Completed
Publish Date: August 19, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

389 Total Publications

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
Journal: Circulation
Published: August 29, 2026

Frequently Asked Questions about Arsene M. Mekinian

Is Arsene M. Mekinian a top-rated expert for VEXAS Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Arsene M. Mekinian is classified as an Elite expert for VEXAS Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Arsene M. Mekinian participate in research or clinical trials?

Yes. Arsene M. Mekinian has published 389 articles and abstracts on conditions like VEXAS Syndrome. You can view a list of Arsene M. Mekinian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mekinian's expertise for a condition
ConditionClose
View All 13 Distinguished Conditions
View All 29 Advanced Conditions
View All 95 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile